Diamyd Medical
16,26
SEK
-0,73 %
DMYD B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
-0,73%
-10,46%
-1,09%
+28,03%
-11,05%
+82,49%
-11,04%
-9,98%
+439%
Diamyd Medical is a diabetes company. The company develops the diabetes vaccine Diamyd® with the active ingredient GAD, which has the potential to become a key piece of the puzzle of a future solution to prevent, treat or cure type 1 diabetes and other forms of diabetes. Diamyd Medical has independently pursued the development of the diabetes vaccine Diamyd® to global Phase III trial.
Læs mereMarkedsværdi
1,69 mia. SEK
Aktieomsætning
1,17 mio. SEK
Omsætning
130 t
EBIT %
-112.746,15 %
P/E
-
Udbytteafkast, %
-
Finanskalender
9.4
2025
Delårsrapport Q2'25
25.6
2025
Delårsrapport Q3'25
8.10
2025
Årsrapport '25
ViserAlle indholdstyper
Diamyd Medical AB: Quarterly Report 1 24/25
Diamyd Medical AB: South Korea to grant precision medicine patent to Diamyd Medical for insulin antigen treatment in autoimmune diabetes
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools